Synthetic GPCRs for programmable sensing and control of cell behaviour
Nature · 02.01.2025 · 637 (8044) · 230-239
DOI: 10.1038/s41586-024-08282-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nature, online erschienen am 04.12.2024. Verfasst von Nicholas A Kalogriopoulos und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Stanford University, Stanford, CA, USA. Hauptthemen laut MEDLINE: Cell Movement, Macrophages, Protein Engineering, Receptors, G-Protein-Coupled. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIMH NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Synthetic receptors that mediate antigen-dependent cell responses are transforming therapeutics, drug discovery and basic research1,2. However, established technologies such as chimeric antigen receptors3 can only detect immobilized antigens, have limited output scope and lack built-in drug control3-7. Here we engineer synthetic G-protein-coupled receptors (GPCRs) that are capable of driving a wide range of native or non-native cellular processes in response to a user-defined antigen. We achieve modular antigen gating by engineering and fusing a conditional auto-inhibitory domain onto GPCR scaffolds. Antigen binding to a fused nanobody relieves auto-inhibition and enables receptor activation by drug, thus generating programmable antigen-gated G-protein-coupled engineered receptors (PAGERs). We create PAGERs that are responsive to more than a dozen biologically and therapeutically important soluble and cell-surface antigens in a single step from corresponding nanobody binders. Different PAGER scaffolds allow antigen binding to drive transgene expression, real-time fluorescence or endogenous G-protein activation, enabling control of diverse cellular functions. We demonstrate multiple applications of PAGER, including induction of T cell migration along a soluble antigen gradient, control of macrophage differentiation, secretion of therapeutic antibodies and inhibition of neuronal activity in mouse brain slices. Owing to its modular design and generalizability, we expect PAGERs to have broad utility in discovery and translational science.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Genetics, Stanford University, Stanford, CA, USA.
- Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China.
- Department of Neurosurgery, Stanford University, Stanford, CA, USA.
- State Key Laboratory of Membrane Biology, New Cornerstone Science Laboratory, School of Life Sciences, Peking University, Beijing, China.
- Department of Genetics, Stanford University, Stanford, CA, USA. ayting@stanford.edu.
- Department of Biology, Stanford University, Stanford, CA, USA. ayting@stanford.edu.
ORCID-Profile: Peter M Klein, Ivan Soltesz, Yulong Li, Alice Y Ting
Förderung
- NIMH NIH HHS
- NINDS NIH HHS
Zitieren
APA
Kalogriopoulos, N. A., Tei, R., Yan, Y., Klein, P. M., Ravalin, M., Cai, B., Soltesz, I., Li, Y., & Ting, A. Y. (2025). Synthetic GPCRs for programmable sensing and control of cell behaviour. Nature, 637(8044), 230-239. https://doi.org/10.1038/s41586-024-08282-3
Vancouver
Kalogriopoulos NA, Tei R, Yan Y, Klein PM, Ravalin M, Cai B, et al. Synthetic GPCRs for programmable sensing and control of cell behaviour. Nature. 2025;637(8044):230-239. doi:10.1038/s41586-024-08282-3
BibTeX
@article{Kalogriopoulos2025,
author = {Kalogriopoulos, Nicholas A and Tei, Reika and Yan, Yuqi and Klein, Peter M and Ravalin, Matthew and Cai, Bo and Soltesz, Ivan and Li, Yulong and Ting, Alice Y},
title = {Synthetic GPCRs for programmable sensing and control of cell behaviour},
journal = {Nature},
year = {2025},
volume = {637},
number = {8044},
pages = {230--239},
doi = {10.1038/s41586-024-08282-3}
}
EUVIMED